Warning: The NCBI web site requires JavaScript to function. more...
Retraction: Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease.
Liu WG, Wang XJ, Lu GQ, Li B, Wang G, Chen SD.
Mol Neurodegener. 2009 Nov 4;4:45. No abstract available.
Related citations
Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease.
Mol Neurodegener. 2007 Oct 1;2:19.
Dopaminergic neuroprotection by neurturin-expressing c17.2 neural stem cells in a rat model of Parkinson's disease.
Liu WG, Lu GQ, Li B, Chen SD.
Parkinsonism Relat Disord. 2007 Mar;13(2):77-88. Epub 2006 Sep 11.
Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
Oiwa Y, Yoshimura R, Nakai K, Itakura T.
Brain Res. 2002 Aug 30;947(2):271-83.
Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
Cui YF, Hargus G, Xu JC, Schmid JS, Shen YQ, Glatzel M, Schachner M, Bernreuther C.
Brain. 2010 Jan;133(Pt 1):189-204. Epub 2009 Dec 7.
Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease.
Sharma R, McMillan CR, Niles LP.
J Pineal Res. 2007 Oct;43(3):245-54.
Persephin-overexpressing neural stem cells regulate the function of nigral dopaminergic neurons and prevent their degeneration in a model of Parkinson's disease.
Akerud P, Holm PC, Castelo-Branco G, Sousa K, Rodriguez FJ, Arenas E.
Mol Cell Neurosci. 2002 Oct;21(2):205-22.
Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model.
Gu S, Huang H, Bi J, Yao Y, Wen T.
Brain Res. 2009 Feb 27;1257:1-9. Epub 2008 Dec 16.
Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
Murrell W, Wetzig A, Donnellan M, Féron F, Burne T, Meedeniya A, Kesby J, Bianco J, Perry C, Silburn P, Mackay-Sim A.
Stem Cells. 2008 Aug;26(8):2183-92. Epub 2008 Jun 5.
Induction of dopaminergic neuronal-like cells from CD44+ human amniotic fluids that are ameliorative to behavioral recovery in a Parkinson's disease rat model.
Liu T, Guo L, Liu Z, Huang Y, Cheng W.
Int J Mol Med. 2011 Nov;28(5):745-52. doi: 10.3892/ijmm.2011.732. Epub 2011 Jun 27.
Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a rhesus monkey model of Parkinson's disease.
Li H, He Z, Su T, Ma Y, Lu S, Dai C, Sun M.
Neurol Res. 2003 Apr;25(3):263-7.
Effect of transplantation of c17.2 cells transfected with interleukin-10 gene on intracerebral immune response in rat model of Parkinson's disease.
Wang XJ, Liu WG, Zhang YH, Lu GQ, Chen SD.
Neurosci Lett. 2007 Aug 16;423(2):95-9. Epub 2007 Jun 28.
Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.
Ye M, Wang XJ, Zhang YH, Lu GQ, Liang L, Xu JY, Chen SD.
Brain Res. 2007 Apr 20;1142:206-16. Epub 2006 Dec 24.
The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease.
Tanriover G, Seval-Celik Y, Ozsoy O, Akkoyunlu G, Savcioglu F, Hacioglu G, Demir N, Agar A.
Folia Histochem Cytobiol. 2010 Sep 30;48(3):434-41.
Neurorestoration in Parkinson's disease by cell replacement and endogenous regeneration.
Hermann A, Gerlach M, Schwarz J, Storch A.
Expert Opin Biol Ther. 2004 Feb;4(2):131-43. Review.
Human umbilical vein-derived dopaminergic-like cell transplantation with nerve growth factor ameliorates motor dysfunction in a rat model of Parkinson's disease.
Li M, Zhang SZ, Guo YW, Cai YQ, Yan ZJ, Zou Z, Jiang XD, Ke YQ, He XY, Jin ZL, Lu GH, Su DQ.
Neurochem Res. 2010 Oct;35(10):1522-9. Epub 2010 Jul 24.
Expression, bioactivity, and safety 1 year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson's disease.
Herzog CD, Brown L, Gammon D, Kruegel B, Lin R, Wilson A, Bolton A, Printz M, Gasmi M, Bishop KM, Kordower JH, Bartus RT.
Neurosurgery. 2009 Apr;64(4):602-12; discussion 612-3.
Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease.
Levy YS, Bahat-Stroomza M, Barzilay R, Burshtein A, Bulvik S, Barhum Y, Panet H, Melamed E, Offen D.
Cytotherapy. 2008;10(4):340-52.
Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
Quinn M, Mukhida K, Sadi D, Hong M, Mendez I.
Eur J Neurosci. 2008 Jan;27(1):43-52. Epub 2007 Dec 15.
Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
Bouchez G, Sensebé L, Vourc'h P, Garreau L, Bodard S, Rico A, Guilloteau D, Charbord P, Besnard JC, Chalon S.
Neurochem Int. 2008 Jun;52(7):1332-42. Epub 2008 Mar 10.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on